Molecule intelOpportunity: Moderate0

Omeprazole Sodium

48 brands · 35 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
41
Market saturation
80
Price room
100
Regulatory risk
50
48
brands
35
companies
Rs 527.9
median price
78
price points
1,127.15x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 12.57
MedianRs 527.9
Most expensiveRs 14,168.33
Spread1,127.15×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 1127.15x across 78 trusted points (Rs 12.57-14168.33). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 1 live product for Omeprazole Sodium — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2026-03-11
14. Recall Alert (Human) – DTLs Punjab Declared substandard drug products.

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(20) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

35 canonical companies and 48 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 1127.15x across 78 trusted points (Rs 12.57-14168.33). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-03-11 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.